Ibandronate sodium injection
Products billed under this code include Ibandronate Sodium.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Ibandronate Sodium.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Ibandronate Sodium | Sagent Pharmaceuticals | 25021-0827-61 | 3 | $131.04 |
| Ibandronate Sodium | Eugia US LLC | 55150-0191-83 | 3 | $131.04 |
| Ibandronate Sodium | Apotex Corp | 60505-6097-00 | 3 | $131.04 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $43.68 | −$1.474 | 1 MG | Ibandronate sodium injection | v1, posted September 17, 2026 |
| 3Q26 | $45.154 | +$36.097 | 1 MG | Ibandronate sodium injection | v1, posted September 15, 2026 |
| 2Q26 | $9.057 | −$4.085 | 1 MG | Ibandronate sodium injection | v1, posted September 15, 2026 |
| 1Q26 | $13.142 | −$15.471 | 1 MG | Ibandronate sodium injection | v1, posted September 15, 2026 |
| 4Q25 | $28.613 | −$2.189 | 1 MG | Ibandronate sodium injection | v1, posted September 8, 2026 |
| 3Q25 | $30.802 | +$8.583 | 1 MG | Ibandronate sodium injection | v1, posted March 10, 2026 |
| 2Q25 | $22.219 | −$3.139 | 1 MG | Ibandronate sodium injection | v1, posted March 10, 2026 |
| 1Q25 | $25.358 | −$1.778 | 1 MG | Ibandronate sodium injection | v1, posted December 19, 2025 |
| 4Q24 | $27.136 | −$1.585 | 1 MG | Ibandronate sodium injection | v1, posted June 11, 2025 |
| 3Q24 | $28.721 | −$2.992 | 1 MG | Ibandronate sodium injection | v1, posted June 11, 2025 |
| 2Q24 | $31.713 | +$6.117 | 1 MG | Ibandronate sodium injection | v1, posted March 11, 2025 |
| 1Q24 | $25.596 | +$0.693 | 1 MG | Ibandronate sodium injection | v1, posted December 19, 2024 |
| 4Q23 | $24.903 | −$4.411 | 1 MG | Ibandronate sodium injection | v1, posted October 10, 2024 |
| 3Q23 | $29.314 | −$1.532 | 1 MG | Ibandronate sodium injection | v1, posted June 5, 2024 |
| 2Q23 | $30.846 | −$3.186 | 1 MG | Ibandronate sodium injection | v1, posted February 23, 2024 |
| 1Q23 | $34.032 | +$8.185 | 1 MG | Ibandronate sodium injection | v1, posted December 6, 2023 |
| 4Q22 | $25.847 | −$7.945 | 1 MG | Ibandronate sodium injection | v1, posted June 22, 2023 |
| 3Q22 | $33.792 | −$11.848 | 1 MG | Ibandronate sodium injection | v1, posted June 9, 2023 |
| 2Q22 | $45.64 | +$16.366 | 1 MG | Ibandronate sodium injection | v1, posted December 14, 2022 |
| 1Q22 | $29.274 | −$7.817 | 1 MG | Ibandronate sodium injection | v1, posted June 8, 2022 |
| 4Q21 | $37.091 | +$0.033 | 1 MG | Ibandronate sodium injection | v1, posted June 2, 2022 |
| 3Q21 | $37.058 | −$1.487 | 1 MG | Ibandronate sodium injection | v1, posted June 2, 2022 |
| 2Q21 | $38.545 | −$2.994 | 1 MG | Ibandronate sodium injection | v1, posted March 1, 2022 |
| 1Q21 | $41.539 | – | 1 MG | Ibandronate sodium injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.